USPTO serial 79366379
LIPOFLUIDICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 25, 2024
- Examiner
- BLAZICH, JOAN MICHELE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with LIPOFLUIDICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Janice Housey
Janice Housey Litmus Law PLLC4 Weems Lane #240Winchester, VA 22601UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Liposomes for non-medical use, namely, industrial chemicals in the nature of liposome encapsulated molecules and vitamins for use in the manufacture of pharmaceutical products and complementary medicines; vitamins for use in the manufacture of food supplements; vitamins for use in the manufacture of pharmaceuticals; mineral preparations for use in manufacturing, namely, mineral acids, minerals being sodium chloride, sodium carbonate and sodium sulfate, potassium being potassium citrate, potassium chloride, potassium phosphate, potassium aspartate, potassium bicarbonate and potassium gluconate, calcium being calcium carbonate and calcium citrate, and magnesium being magnesium aspartate, magnesium citrate, magnesium oxide, magnesium chloride, magnesium lactate, magnesium malate, magnesium taurate, magnesium L-threonate, magnesium sulfate, magnesium glycinate and magnesium orotate and trace elements being iron being ferrous sulfate, ferrous gluconate, ferric citrate, and ferric sulfate, copper being cupric oxide, cupric sulfate, copper gluconate, and copper amino acid chelates, zinc being zinc picolinate, zinc citrate, zinc acetate, zinc glycerate, and zinc monomethionine, selenium, iodine, chromium being chromium picolinate, chromium nicotinate, chromium polynicotinate, chromium chloride, and chromium histidinat, manganese being manganese sulfate, manganese gluconate and manganese chelate, and molybdenum being molybdenum chloride, sodium molybdate, molybdenum glycinate, and molybdenum amino acid chelate; chemical products and chemical substances, namely, chemical additives, for use in the manufacture of medicinal and pharmaceutical preparations and substances; enzymes for scientific purposes; fats and sugars being chemical substances for medicine manufacture, namely, lipids, phospholipids, carbohydrates, carbohydrate conjugates and industrial purpose sugar alcohols for use in the manufacture of medicines | ACTIVE | — |
| 005 | Complementary medicines including liposomal nutrients, namely, dietary supplements, nutritional supplements and vitamin supplements; dietary supplements; dietetic food supplements adapted for medical purposes; enzyme dietary supplements; food supplements being dietary supplements; food supplements for medical purposes; medicinal herbal preparations; herbal dietary supplements; vitamins; minerals being mineral supplements; medicated preparations for use as supplements for food; mineral food supplements; mineral preparations for use as dietary supplements to drinking water; nutritional supplements; protein dietary supplements; protein supplements for humans; supplements containing trace elements for foodstuffs for human consumption; vitamin preparations in the nature of food supplements; pharmaceutical preparations in the nature of dietary supplements, nutritional supplements and medicinal herbal supplements for health care; probiotics, namely, probiotic supplements; nutritional, medicinal and naturopathic preparations, and adjuvants for the aforementioned goods, namely, dietary supplements, nutritional supplements, food supplements being dietary supplementsand medicinal herbal supplements; amino acids for nutritional purposes; pharmaceutical products derived from natural sources, namely, dietary supplements, nutritional supplements, food supplements being dietary supplementsand medicinal herbal supplements; edible fish oil for medical purposes; evening primrose oil for medical use; esters of fatty acids for use as pharmaceutical preparations, namely, dietary supplements, nutritional supplements and food supplements being dietary supplementscontaining esters of fatty acids | ACTIVE | — |
| 040 | Custom manufacture of goods in the nature of complementary medicines, traditional medicines, dietary supplements, nutritional supplements and medicinal herbal supplements; assembly of customized materials in the nature of complementary medicines, traditional medicines, dietary supplements, nutritional supplements and medicinal herbal supplements for others; medicinal materials treatment and processing; complementary medicines materials treatment and processing; material and product, namely, complementary medicines, traditional medicines, dietary supplements, nutritional supplements and medicinal herbal supplements processing services; chemistry reagent processing; treatment of materials in the nature of complementary medicines, traditional medicines, dietary supplements and medicinal herbal supplements; pharmaceutical filtration services being pharmaceutical processing services; processing of biopharmaceutical materials for others; custom fabricating, making or manufacturing of goods or materials, namely, manufacture of complementary medicines, traditional medicines, dietary supplements and medicinal herbal supplements for others; advisory, consultancy and information services in respect of all of the aforementioned services | ACTIVE | — |
| 042 | Research and development services in respect of complementary medicines and nanoparticle delivery systems; research services in the field of natural health; product development services in respect of complementary medicines; technical research in the field of complementary medicines studies; research and development of new products for others; science laboratory services; scientific research; quality control of complementary medicines services; quality testing services; quality assessment services, namely, product quality testing services in respect of complementary medicines and traditional medicines; chemical analysis and research services; bacteriological research services; clinical trials; medical research services; complementary medicine research, testing and development services; packaging design; technological services, namely, scientific research in respect of complementary medicines, dietary supplements, medicinal herbal supplements and nanoparticle delivery systems; industrial analysis and research services in the field of complementary medicines, traditional medicines and nanoparticle delivery systems; research and development in the field of therapeutics; research, development, scientific analysis and quality, safety and efficacy evaluation services in connection with biotechnology, microorganisms, pharmaceuticals, medicine, microbiome, biochemistry, probiotics, prebiotics, nutritional supplements; dietary supplements and nutraceutical supplements; advisory, consultancy and information services in respect of all of the aforementioned services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Spectrumceuticals Pty Ltd
- Other trademarks owned by Spectrumceuticals Pty Ltd
- Other trademarks owned by Spectrumceuticals Pty Ltd
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named LIPOFLUIDICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 28, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 10, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 10, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 25, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 25, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 25, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 16, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 9, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 9, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 27, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 27, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 20, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 4, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 4, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 4, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 4, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 4, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 21, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 21, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 21, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 6, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 18, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 18, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 2, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 1, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 28, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 31, 2023 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Oct 1, 2023 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Apr 7, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 3, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 30, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |